Navigation Links
Accuray Incorporated to Host Investor and Analyst Meeting at ASTRO
Date:10/8/2009

SUNNYVALE, Calif., Oct. 8 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, will host an Investor and Analyst Meeting in Chicago, Ill., on Monday, November 2, 2009 at 3:00 p.m. EDT/12:00 p.m. PDT. This meeting will coincide with the 51st Annual Meeting of the American Society for Radiation Oncology (ASTRO).

A live webcast of the presentation will be available online from the Investor Relations page of the Company's Web site at http://www.accuray.com. The webcast replay of the presentation will begin approximately one hour after the conclusion of the live presentation and will be available for approximately 30 days.

About the CyberKnife(®) Robotic Radiosurgery System

The CyberKnife Robotic Radiosurgery System is the world's only robotic radiosurgery system designed to treat tumors anywhere in the body non-invasively. Using continual image guidance technology and computer controlled robotic mobility, the CyberKnife System automatically tracks, detects and corrects for tumor and patient movement in real-time throughout the treatment. This enables the CyberKnife System to deliver high-dose radiation with pinpoint precision, which minimizes damage to surrounding healthy tissue and eliminates the need for invasive head or body stabilization frames.

About Accuray

Accuray Incorporated (Nasdaq: ARAY), based in Sunnyvale, Calif., is a global leader in the field of radiosurgery dedicated to providing an improved quality of life and a non-surgical treatment option for those diagnosed with cancer. Accuray develops and markets the CyberKnife Robotic Radiosurgery Sy
'/>"/>

SOURCE Accuray Incorporated
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Accuray Incorporated to Present at Robert Baird 2009 Healthcare Conference
2. Accuray to Showcase CyberKnife Treatment Planning Capabilities at Preeminent Radiation Oncology Conference
3. 10 Percent of U.S. Installed Base Signs on to Use Accuray Treatment Planning Service
4. Accuray Incorporated to Report Second Quarter Fiscal Year 2009 Financial Results
5. Accuray Incorporateds CEO to Speak at 27th Annual JP Morgan Healthcare Conference
6. Accuray Achieves Milestone of 150th CyberKnife System Installed Worldwide
7. Accuray Postpones Release of First Quarter Fiscal 2009 Results
8. Accuray Reschedules Announcement of Results for First Quarter of Fiscal 2009
9. Accuray Incorporateds CEO to Speak at UBS Global Life Sciences Conference
10. Accuray Incorporated to Host Investor and Analyst Meeting at ASTRO
11. Accuray Announces Results for the Fourth Quarter and Fiscal Year End 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... Halifax, Nova Scotia (PRWEB) February 27, 2015 ... has been made aware of a fraudulent press release ... GlobeNewswire, purporting to be from Immunovaccine. This press release ... with Gilead Science, Inc. The press release did ... to the information contained within the press release. ...
(Date:2/27/2015)... Mass. , Feb. 27, 2015 ... of the NCATS rare-diseases portfolio " in ... a new financing technique to reduce the risk ... diseases and potentially unlock new levels of funding ... The product of a unique collaboration between scientists ...
(Date:2/27/2015)... 27, 2015 The fully automated ... UC) can sequentially analyze up to 48 samples ... high-sensitivity detection of targets by mass spectrometry. ... fulfill the measurement requirements of a wide range ... drug delivery and search for disease biomarkers, additives ...
(Date:2/27/2015)... FamilyFarms Group is pleased to announce its valued ... received the 2015 Tomorrow’s Top Producer Horizon Award. The ... 35, who has demonstrated excellence in the business of ... Tomorrow's Top Producer Horizon Award. Every year I look ... and learning from their experiences. It is truly humbling ...
Breaking Biology Technology:Immunovaccine Disclaims Hoax Press Release 2New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 2New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 3New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 4Shimadzu Corporation Launches Nexera UC - The World’s Foremost Unified Chromatography System 2Shimadzu Corporation Launches Nexera UC - The World’s Foremost Unified Chromatography System 3Matt Sims Receives the 2015 Tomorrow’s Top Producer Horizon Award 2
... 25, 2011 Projects In Knowledge, a fully accredited ... digital and mobile information tools for busy clinicians, has ... The company,s website ( www.projectsinknowledge.com ) won an Award ... "Most Improved Web and Intranet Site." Launched in August ...
... Mich., July 25, 2011 Robert Ettinger, the founder of ... Saturday, July 23, at home in Clinton Township, Michigan, and ... storage at very low temperatures after death in the hope ... aging and disease. Mr. Ettinger wrote ...
... -   Text-to-speech application enables researchers to listen ...  Elsevier, a world leading provider of scientific, technical ... of an audio reader application from iSpeech, provider of cloud-based ... . The iSpeech Audio Reader is the latest in a ...
Cached Biology Technology:Two Health Industry Award Wins for Projects In Knowledge® 2Two Health Industry Award Wins for Projects In Knowledge® 3Founder of Cryonics Movement Dies, is Frozen at Cryonics Institute 2iSpeech® Develops Audio Reader for Elsevier's SciVerse Applications 2iSpeech® Develops Audio Reader for Elsevier's SciVerse Applications 3iSpeech® Develops Audio Reader for Elsevier's SciVerse Applications 4
(Date:2/5/2015)... Calif. , Jan. 30, 2015  It is ... great power and potential for genomic science as a ... in disease prevention and treatment.  I was honored to ... new, government-funded precision medicine program. Since ... the science of genomics—from the first sequenced genome of ...
(Date:1/22/2015)... , Jan. 22, 2015 Research and Markets ( ... - A Global Market Overview" report to their offering. ... is to ensure that an individual is who she/he is ... make use of a person,s unique physical characteristics, such as ...
(Date:1/22/2015)... /PRNewswire/ - Today, FindBiometrics, the leading source of biometrics industry news, ... website design. "When we launched FindBiometrics 12 years ... O,Neill , founder and CEO of FindBiometrics. "Now it,s maturing ... the key players on a very broad scale.  We are ...
Breaking Biology News(10 mins):J. Craig Venter, Ph.D., Co-Founder and CEO, Human Longevity, Inc. (HLI) Participates in White House Precision Medicine Event 2Biometrics - A Global Market Overview 2Biometrics - A Global Market Overview 3Identity Industry Leading Publication Debuts New Look As Biometrics Hit Mainstream 2
... in melanoma therapy. Patients whose melanoma lesions contain a ... a BRAF-specific inhibitor, PLX4032. Reports of the drug trial ... after therapy began the tumors returned and resumed growing. ... tumor learns to signal around the blocked gene by ...
... the southwestern United States are changing and will face ... declines during this century, according to a study conducted ... Service; University of California, Santa Barbara; U.S. Geological Survey; ... in the Proceedings of the National Academy of ...
... that the speed of early forest clearance following human ... much faster and more intense than previously thought. ... just a few large fires within 200 years of ... forest. Grasslands and shrubland replaced the burnt forest and ...
Cached Biology News:Killing drug-resistant melanoma requires combination therapy 2Killing drug-resistant melanoma requires combination therapy 3Drought and rising temperatures weaken southwest forests 2Early settlers rapidly transformed New Zealand forests with fire 2Early settlers rapidly transformed New Zealand forests with fire 3
Histone H2A Polyclonal Antibody 100 ug affinity purified rabbit polyclonal antibody. Detects ~14 kDa Histone H2A. It does not cross-react with other Histones. Reacts with human/mouse/rat. Performs w...
...
CMRL Medium-1066 (1X) liquid...
MMP-20 Immunogen: Activated recombinant human MMP-2 Storage: -20 C, Avoid Freeze/Thaw Cycles...
Biology Products: